News
Novo Nordisk Sues Eli Lilly Over ‘Misleading’ Weight-Loss Ads; LLY Slips 1% After Hours
Novo Nordisk has taken its rivalry with Eli Lilly to federal court, accusing the drugmaker of using outdated clinical data in ads for Zepbound and Mounjaro to unfairly trash Wegovy and Ozempic. Lilly fired back, calling its ads truthful and science-based.
